Gemtuzumab ozogamicin加上midostaurin与标准强化疗法联合治疗FLT3突变的急性髓细胞白血病患者-捷克中心的经验。
Gemtuzumab ozogamicin plus midostaurin in conjunction with standard intensive therapy for FLT3-mutated acute myeloid leukemia patients - Czech Center experience.
发表日期：2023 Feb 23
作者：
Barbora Weinbergerová, Martin Čerňan, Tomáš Kabut, Lukáš Semerád, Natália Podstavková, Tomáš Szotkowski, Ivana Ježíšková, Jiří Mayer
来源：
HAEMATOLOGICA
摘要：
不可用。
Not available.